Chargement en cours...
Targeting glucose metabolism in cancer: a new class of agents for loco-regional and systemic therapy of liver cancer and beyond?
Hepatocellular carcinoma (HCC) is one of the most prevalent cancers and the third leading cause of cancer-related deaths worldwide. In patients with unresectable disease, loco-regional catheter-based intra-arterial therapies (IAT) can achieve selective tumor control while minimizing systemic toxicit...
Enregistré dans:
| Publié dans: | Hepat Oncol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Future Medicine Ltd
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4792180/ https://ncbi.nlm.nih.gov/pubmed/26989470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep.15.36 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|